KEYTRUDA® (pembrolizumab) for Unresectable or Metastatic Melanoma - Cancer Therapy Advisor

KEYTRUDA® (pembrolizumab) for Unresectable or Metastatic Melanoma

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for KEYTRUDA® (pembrolizumab), indicated for unresectable or metastatic melanoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 7: Use in Specific Populations
Slide 9: Clinical Pharmacology
Slide 13: Warnings and Precautions
Slide 15: Clinical Safety and Efficacy
Slide 20: Drug Storage and SupplySlide 22: References

Next hm-slideshow in Slides